TVG’s BRSV vaccine recognised among the UK’s major animal research breakthroughs in 2025

The Vaccine Group’s bovine respiratory syncytial virus (BRSV) vaccine programme has been recognised in the 2025 Animal Research Breakthroughs Review published by Understanding Animal Research, highlighting the progress of the BoHV-4-vectored vaccine approach designed to protect very young calves, including in the presence of maternal antibodies. BRSV remains one of the leading infectious contributors to bovine respiratory […]